Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Enzyme (Pancreatic Enzymes, Agalsidase Beta), By Therapeutic Condition, By Route Of Administration, By End Use, And Segment Forecasts, 2019 - 2026
- Report ID: GVR-3-68038-999-9
- Number of Pages: 125
- Format: Electronic (PDF)
- Historical Range: 2015 - 2017
- Industry: Healthcare
Market Segmentation
- Enzyme Outlook (Revenue, USD Million; 2015 - 2026)
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Therapeutic Condition Outlook (Revenue, USD Million; 2015 - 2026)
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Route of Administration Outlook (Revenue, USD Million; 2015 - 2026)
- Oral
- Parenteral
- End-Use Outlook (Revenue, USD Million; 2015 - 2026)
- Hospitals
- Infusion Centers
- Others
- Regional Outlook (Revenue, USD Million; 2015 - 2026)
- North America
- North America Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- North America Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- North America Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- North America Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Canada
- Canada Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Canada Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Canada Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Canada Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- The U.S.
- U.S. Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- U.S. Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- U.S. Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- U.S. Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- U.S. Enzyme Replacement Therapy Market, By Enzyme
- North America Enzyme Replacement Therapy Market, By Enzyme
- Europe
- Europe Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Europe Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Europe Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Europe Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Germany
- Germany Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Germany Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Germany Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Germany Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Germany Enzyme Replacement Therapy Market, By Enzyme
- UK
- UK Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- UK Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- UK Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- UK Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- UK Enzyme Replacement Therapy Market, By Enzyme
- France
- France Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- France Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- France Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- France Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- France Enzyme Replacement Therapy Market, By Enzyme
- Italy
- Italy Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Italy Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Italy Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Italy Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Italy Enzyme Replacement Therapy Market, By Enzyme
- Spain
- Spain Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Spain Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Spain Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Spain Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Spain Enzyme Replacement Therapy Market, By Enzyme
- Russia
- Russia Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Russia Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Russia Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Russia Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Russia Enzyme Replacement Therapy Market, By Enzyme
- Europe Enzyme Replacement Therapy Market, By Enzyme
- Asia Pacific
- Asia Pacific Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Asia Pacific Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Asia Pacific Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Asia Pacific Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Japan
- Japan Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Japan Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Japan Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Japan Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Japan Enzyme Replacement Therapy Market, By Enzyme
- China
- China Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- China Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- China Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- China Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- China Enzyme Replacement Therapy Market, By Enzyme
- India
- India Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- India Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- India Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- India Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- India Enzyme Replacement Therapy Market, By Enzyme
- Australia
- Australia Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Australia Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Australia Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Australia Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Australia Enzyme Replacement Therapy Market, By Enzyme
- South Korea
- South Korea Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- South Korea Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- South Korea Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- South Korea Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- South Korea Enzyme Replacement Therapy Market, By Enzyme
- Latin America
- Latin America Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Latin America Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Latin America Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Latin America Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Brazil
- Brazil Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Brazil Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Brazil Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Brazil Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Brazil Enzyme Replacement Therapy Market, By Enzyme
- Mexico
- Mexico Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Mexico Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Mexico Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Mexico Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Mexico Enzyme Replacement Therapy Market, By Enzyme
- Argentina
- Argentina Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Argentina Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Argentina Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Argentina Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Argentina Enzyme Replacement Therapy Market, By Enzyme
- Latin America Enzyme Replacement Therapy Market, By Enzyme
- MEA
- MEA Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- MEA Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- MEA Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- MEA Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- South Africa
- South Africa Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- South Africa Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- South Africa Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- South Africa Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- South Africa Enzyme Replacement Therapy Market, By Enzyme
- Saudi Arabia
- Saudi Arabia Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- Saudi Arabia Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- Saudi Arabia Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- Saudi Arabia Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- Saudi Arabia Enzyme Replacement Therapy Market, By Enzyme
- UAE
- UAE Enzyme Replacement Therapy Market, By Enzyme
- Imiglucerase
- Agalsidase Beta
- Taliglucerase
- Velaglucerase Alfa
- Laronidase
- Alglucosidase Alfa
- Galsulfase
- Idursulfase
- Pancreatic Enzymes
- Pegademase
- Others
- UAE Enzyme Replacement Therapy Market, By Therapeutic Condition
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- SCID
- MPS
- MPS I - Hurler, Hurler Scheie and Scheie
- MPS II - Hunter
- MPS III - Sanfilippo
- Others
- Others
- UAE Enzyme Replacement Therapy Market, By Route of Administration
- Oral
- Parenteral
- UAE Enzyme Replacement Therapy Market, By End-use
- Hospitals
- Infusion Centers
- Others
- UAE Enzyme Replacement Therapy Market, By Enzyme
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2015 to 2026
- Market estimates and forecast for product segments up to 2026
- Regional market size and forecast for product segments up to 2026
- Market estimates and forecast for application segments up to 2026
- Regional market size and forecast for application segments up to 2026
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
